193 related articles for article (PubMed ID: 33971363)
1. Oxaliplatin hypersensitivity complicated by thrombocytopenia during desensitization.
Tuttle KL; Stavrou E; Hong DIC; Connell NT; Wickner P
Ann Allergy Asthma Immunol; 2021 Aug; 127(2):267-269. PubMed ID: 33971363
[No Abstract] [Full Text] [Related]
2. Desensitizing oxaliplatin-induced fever: a case report.
Madrigal-Burgaleta R; Berges-Gimeno MP; Angel-Pereira D; Guillen-Ponce C; Sanz ML; Alvarez-Cuesta E
J Investig Allergol Clin Immunol; 2013; 23(6):435-6. PubMed ID: 24459821
[No Abstract] [Full Text] [Related]
3. Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule.
Meyer L; Zuberbier T; Worm M; Oettle H; Riess H
J Clin Oncol; 2002 Feb; 20(4):1146-7. PubMed ID: 11844841
[No Abstract] [Full Text] [Related]
4. Hypersensitivity and idiosyncratic reactions to oxaliplatin.
Bhargava P; Gammon D; McCormick MJ
Cancer; 2004 Jan; 100(1):211-2. PubMed ID: 14692042
[No Abstract] [Full Text] [Related]
5. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment.
Madrigal-Burgaleta R; Berges-Gimeno MP; Angel-Pereira D; Ferreiro-Monteagudo R; Guillen-Ponce C; Pueyo C; Gomez de Salazar E; Alvarez-Cuesta E
Allergy; 2013 Jul; 68(7):853-61. PubMed ID: 23647576
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Prolonged Infusion on Reducing Oxaliplatin Hypersensitivity Reactions.
Zhang X; Zhao Y; Zheng Y; Dong Y
J Investig Allergol Clin Immunol; 2017; 27(1):65-66. PubMed ID: 28211349
[No Abstract] [Full Text] [Related]
7. Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol.
Gammon D; Bhargava P; McCormick MJ
Oncologist; 2004; 9(5):546-9. PubMed ID: 15477639
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
Wong JT; Ling M; Patil S; Banerji A; Long A
J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
[TBL] [Abstract][Full Text] [Related]
9. Successful Desensitization to Oxaliplatin After a Single Initial Dose of Omalizumab in a Patient With Elevated IgE Levels.
Penella J; Quan P; Carvallo A; Chopitea A; Sala P; García Del Barrio MA; Gastaminza G; Goikoetxea MJ
J Investig Allergol Clin Immunol; 2020; 30(4):293-295. PubMed ID: 32101174
[No Abstract] [Full Text] [Related]
10. Desensitization with oxaliplatin in patients intolerant of carboplatin desensitization.
Rose PG; Metz C; Link N
Int J Gynecol Cancer; 2014 Nov; 24(9):1603-6. PubMed ID: 25304679
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin-induced immune mediated thrombocytopenia.
Beg MS; Komrokji RS; Ahmed K; Safa MM
Cancer Chemother Pharmacol; 2008 Oct; 62(5):925-7. PubMed ID: 18204841
[TBL] [Abstract][Full Text] [Related]
12. Hypersensitivity reactions to oxaliplatin and other antineoplastic agents.
Syrigou E; Syrigos K; Saif MW
Curr Allergy Asthma Rep; 2008 Mar; 8(1):56-62. PubMed ID: 18377776
[TBL] [Abstract][Full Text] [Related]
13. Successful desensitization to oxaliplatin.
Mis L; Fernando NH; Hurwitz HI; Morse MA
Ann Pharmacother; 2005 May; 39(5):966-9. PubMed ID: 15784807
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin-desensitization procedure is safe and feasible in an outpatient cancer unit in France.
Botsen D; Lepoix E; Mazza C; Brasseur M; Grange A; Slimano F; Bouché O
Support Care Cancer; 2019 Sep; 27(9):3179-3182. PubMed ID: 31102054
[TBL] [Abstract][Full Text] [Related]
15. Desensitization to oxaliplatin with two stages of premedication in a patient with metastatic rectal cancer.
Nozawa H; Muto Y; Yamada Y
Clin Ther; 2008 Jun; 30(6):1160-5. PubMed ID: 18640472
[TBL] [Abstract][Full Text] [Related]
16. Skin test protocol for the prevention of hypersensitivity reactions to oxaliplatin.
Pagani M; Bonadonna P
Anticancer Res; 2014 Jan; 34(1):537-40. PubMed ID: 24403513
[TBL] [Abstract][Full Text] [Related]
17. Successful desensitization protocol for hypersensitivity reactions caused by oxaliplatin.
Rosique-Robles D; Vicent Verge JM; Borrás-Blasco J; Giner-Marco V; Casterá E; Galan-Brotons A; Abad J
Int J Clin Pharmacol Ther; 2007 Nov; 45(11):606-10. PubMed ID: 18077926
[TBL] [Abstract][Full Text] [Related]
18. Hypersensitivity reactions to oxaliplatin: a case report and the success of a continuous infusional desensitization schedule.
Lim KH; Huang MJ; Lin HC; Su YW; Chang YF; Lin J; Chang MC; Hsieh RK
Anticancer Drugs; 2004 Jul; 15(6):605-7. PubMed ID: 15205605
[TBL] [Abstract][Full Text] [Related]
19. [Three cases of fatal thrombocytopenia after oxaliplatin-based chemotherapy].
Osumi H; Shinozaki E; Kumekawa Y; Ogura M; Ozaka M; Suenaga M; Matsusaka S; Chin K; Mizunuma N; Yokoyama M
Gan To Kagaku Ryoho; 2013 Nov; 40(11):1557-60. PubMed ID: 24231715
[TBL] [Abstract][Full Text] [Related]
20. Does Rapid Drug Desensitization to Chemotherapy Affect Survival Outcomes?
Berges-Gimeno MP; Carpio-Escalona LV; Longo-Muñoz F; Bernal-Rubio L; Lopez-Gonzalez P; Gehlhaar P; Pachon V; Ferreiro-Monteagudo R; Madrigal-Burgaleta R; Alvarez-Cuesta E
J Investig Allergol Clin Immunol; 2020; 30(4):254-263. PubMed ID: 31188129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
